Financhill
Sell
37

ZVRA Quote, Financials, Valuation and Earnings

Last price:
$8.00
Seasonality move :
-13.78%
Day range:
$7.81 - $8.09
52-week range:
$4.20 - $9.76
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
16.27x
P/B ratio:
11.34x
Volume:
690.2K
Avg. volume:
409.9K
1-year change:
33.61%
Market cap:
$449.7M
Revenue:
$23.6M
EPS (TTM):
-$2.26

Earnings Data

Next earnings date for ZVRA
May 08
2025
Most recent earnings per share
-$0.69
Missed by $0.29
(Mar 11/2025)
Consensus Estimate
-$0.40
(Mar 11/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ZVRA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/08/2025 Q1 $17M -- -- -$0.19 --
03/11/2025 Q4 $8.9M $12M -$0.69 -$0.40 -$0.29
11/12/2024 Q3 $4.9M $3.7M -$0.69 -$0.41 -$0.28
08/13/2024 Q2 $4.4M $4.4M -$0.48 -$0.44 -$0.04
05/08/2024 Q1 $3.8M $3.4M -$0.40 -$0.48 $0.08
03/28/2024 Q4 $11.7M $12.9M -$0.54 -$0.27 -$0.27
11/07/2023 Q3 $3.4M $2.9M -$0.30 -$0.30 -$0.00
08/14/2023 Q2 $3M $8.5M -$0.08 -$0.34 $0.26
05/15/2023 Q1 $2.7M $3.2M -$0.38 -$0.23 -$0.15
03/07/2023 Q4 $3.1M $2M $0.16 -$0.18 $0.34
11/09/2022 Q3 -- $2.9M -$0.19 -- --
06/30/2022 Q2 -- $1.3M -$0.70 -- --
03/31/2022 Q1 -- $4M -$0.05 -- --
12/31/2021 Q4 -- $2.6M $0.05 -- --
09/30/2021 Q3 -- $2M -$0.05 -- --
06/30/2021 Q2 -- $12M -$0.40 -- --
03/31/2021 Q1 -- $12.1M -$2.49 -- --
12/31/2020 Q4 -- $2.4M -$1.13 -- --
09/30/2020 Q3 -- $1.9M -$0.68 -- --
06/30/2020 Q2 -- $6.9M $0.21 -- --
03/31/2020 Q1 -- $2.1M -$1.92 -- --
12/31/2019 Q4 -- $1.4M -$2.83 -- --
09/30/2019 Q3 -- $11.5M $0.96 -- --
06/30/2019 Q2 -- -- -$5.28 -- --
03/31/2019 Q1 -- -- -$7.36 -- --
12/31/2018 Q4 -- -- $2.88 -- --
09/30/2018 Q3 -- -- -$15.04 -- --
06/30/2018 Q2 -- -- -$14.56 -- --
03/31/2018 Q1 -- -- -$28.32 -- --
12/31/2017 Q4 -- -- -$11.52 -- --
09/30/2017 Q3 -- -- -$10.88 -- --
06/30/2017 Q2 -- -- -$7.04 -- --
03/31/2017 Q1 -- -- -$17.76 -- --
12/31/2016 Q4 -- -- -$10.88 -- --
09/30/2016 Q3 -- -- -$14.72 -- --
06/30/2016 Q2 -- -- $9.28 -- --
03/31/2016 Q1 -- -- -$3.20 -- --
12/31/2015 Q4 -- -- -$10.24 -- --
09/30/2015 Q3 -- -- -$10.88 -- --
06/30/2015 Q2 -- -- -$39.20 -- --
03/31/2015 Q1 -- -- -$7.77 -- --

Zevra Therapeutics Earnings Questions

  • How Much did Zevra Therapeutics Generate in Revenue Last Quarter?

    Zevra Therapeutics reported $12M worth of top line sales in its most recent quarter.

  • Did Zevra Therapeutics Beat Earnings Last Quarter?

    Zevra Therapeutics announced earnings per share of -$0.69 which represents a miss of analyst forecast a -$0.40 per share.

  • Is Zevra Therapeutics Profitable?

    Zevra Therapeutics reported $10.7M that represents $0.20 per share over the last quarter.

  • What is the Analyst Consensus for Zevra Therapeutics EPS Next Year?

    Zevra Therapeutics's earnings are forecast to decrease from -$2.28 per share to -$1.93 per share next year representing a decrease of -76.84%.

  • When is Zevra Therapeutics's Earnings Date?

    Zevra Therapeutics's next earnings date is May 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Roblox Stock a Buy, Sell or Hold?
Is Roblox Stock a Buy, Sell or Hold?

Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
50
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
82
EXOD alert for Mar 21

Exodus Movement [EXOD] is up 17.89% over the past day.

Buy
69
SIG alert for Mar 20

Signet Jewelers [SIG] is down 0.64% over the past day.

Sell
36
HQY alert for Mar 20

HealthEquity [HQY] is up 0.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock